Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants. - Wikidata - awgldk - TriplyDB

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.

http://www.wikidata.org/entity/Q39238988

about

Metabolic syndrome in patients with psoriasis: A comparative study.Psoriasis beyond the skin: an expert group consensus on the management of psoriatic arthritis and common co-morbidities in patients with moderate-to-severe psoriasis Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom.Associations between cardiovascular risk factors and psoriasis in Iran.Metabolic syndrome in patients with psoriatic disease.Presence of selected metabolic syndrome components in patients with psoriasis vulgaris.Metabolic syndrome and skin: psoriasis and beyond.Obesity and dyslipidemia in patients with psoriasis treated at a dermatologic clinic in Manaus.Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based cross-sectional study Management of psoriasis in Africa and the Middle East: a review of current opinion, practice and opportunities for improvement.Co-morbidities in psoriasis: a hospital-based case-control study.An update on psoriasis and metabolic syndrome: A meta-analysis of observational studies.Crosstalk between skin inflammation and adipose tissue-derived products: pathogenic evidence linking psoriasis to increased adiposity.Metabolic syndrome in Moroccan patients with psoriasis.High prevalence of metabolic syndrome in patients with psoriasis in Lebanon: a prospective study.Psoriasis and comorbidities in a southern Brazilian population: a case-control study.

P2860

Q33647531-FFDEE074-97AE-424F-AAB0-D8D69D6F732D Q34643790-0E749A44-D363-4FC2-908A-CD7918A77B9B Q35753936-BDECF0AD-6100-42CF-9F15-5B2652150BE7 Q35954321-2D27D0C6-8492-49F9-BAC6-E103409EC9AC Q36897095-581EC412-0A1E-4772-9EB6-5FA6E529CE17 Q36946167-9349FECC-2DE1-489D-A09B-774CD98AE7EF Q37054329-02B50868-CDC0-4D85-A497-7A9DEBDC5C1A Q37509430-544C044F-F5D1-4485-B281-1DE31B67E56A Q37644609-1A549B5F-CC37-421E-8AD4-D7210DFF027F Q37961072-AEF65AC7-94EF-4FB1-BD48-BDB92C77FC77 Q38429390-2738E439-7521-4A10-BEED-3434CE081D24 Q38673766-6BA32E0E-F646-4E0B-972F-DD39A30E6DF4 Q38870692-6743D703-23EC-47B8-B508-1E26AF7F1BAB Q39248840-55DBD6BE-2DAC-4171-8234-F5FE848F28B1 Q40988865-589C8B41-B4D7-41DC-A49A-B140AD546C9E Q48245405-444703C7-1B47-4DF4-BC4D-B60B1446F878

P2860

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.

http://www.wikidata.org/entity/Q39238988

description

2010 nî lūn-bûn

@nan

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

2010年论文

@zh

2010年论文

@zh-cn

name

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.

@en

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.

@nl

type

label

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.

@en

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.

@nl

prefLabel

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.

@en

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants.

@nl

P1433

Q39238988-14F98058-0979-4929-8E18-616BC9370308

P1476

Q39238988-A4679756-DAE7-49FE-9E6F-0EB7D4109557

P2093

Q39238988-0E681EFE-A9D9-49E3-B7D8-FAB774AA0557

Q39238988-3616992B-328F-494E-98A5-31CA9464C8A7

Q39238988-5489A0B6-F405-4F4D-98CB-E33F50C71FFF

Q39238988-6898AE93-5123-473B-B1C8-215B05DD7776

Q39238988-6C8294D9-32A2-4789-B8D2-4CAF16C8010A

Q39238988-8B7558A6-F6DF-44CC-BA58-E8B058083C13

Q39238988-AEC20ECF-0428-436B-9AC6-BFF4BEB71A15

Q39238988-AFECB072-C05D-4687-ABDB-271718146D6F

Q39238988-B93B246B-B55B-4604-89DC-7C0941A74D93

Q39238988-BE72CEF4-3F05-43EA-A02D-B2EE1E3C39D1

P2860

Q39238988-05393DDC-A376-4423-BB95-486D85A014F1

Q39238988-09154B08-372E-4EB6-B44C-F5194B9D513A

Q39238988-199F0864-BCF9-4255-81D9-C6885915F529

Q39238988-35136D57-8E86-4E3A-B193-A0E59103C81A

Q39238988-4200752A-3754-47DA-A2E8-83E94CA75720

Q39238988-93F9114E-07DF-4926-8F5D-5339E53FDDA6

Q39238988-98CCFD35-80B7-469A-B4B0-F286D106E0C3

Q39238988-C6DE1AFF-64A6-4A77-B0E6-8B0911E256BF

Q39238988-CBBFE3AC-113E-4AF8-913D-D6B0C3D561B9

Q39238988-DE57908E-6ABB-4C62-B254-5A22BEB39C57

P304

Q39238988-07266290-3C87-48D1-8637-67CECBF24A1F

P31

Q39238988-97EBCEFA-B100-4295-B2FD-554945E47729

P356

Q39238988-6F58A944-F77A-42A3-AB55-8A95FD974775

P433

Q39238988-B939C6C8-8875-45B3-B93C-32C9ED81FFED

P478

Q39238988-D6ABE823-BE72-4316-B579-A6294121AAE7

P50

Q39238988-4406CE81-0DCE-4851-A680-F37409B4AA3B

P577

Q39238988-E5CAE63C-0CB8-4CE9-B48D-8B6107DAD3D8

P698

Q39238988-2EF11766-BA10-4D4F-BD10-6B67EC3CFD95

P921

Q39238988-D9369655-5750-4770-9024-82734089B786

P356

J.1468-3083.2010.03856.X

P1433

Journal of the European Academy of Dermatology and Venereology

P1476

Metabolic syndrome in Tunisian psoriatic patients: prevalence and determinants

@en

P2093

A Ben Osman

http://www.w3.org/2001/XMLSchema#string

A Mebazaa

http://www.w3.org/2001/XMLSchema#string

F Kanoun

http://www.w3.org/2001/XMLSchema#string

H Slimane

http://www.w3.org/2001/XMLSchema#string

M El Asmi

http://www.w3.org/2001/XMLSchema#string

M Feki

http://www.w3.org/2001/XMLSchema#string

M Mokni

http://www.w3.org/2001/XMLSchema#string

N Kaabachi

http://www.w3.org/2001/XMLSchema#string

R Cheikh Rouhou

http://www.w3.org/2001/XMLSchema#string

S El Ounifi

http://www.w3.org/2001/XMLSchema#string

P2860

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Dislipidemia and oxidative stress in mild and in severe psoriasis as a risk for cardiovascular disease.

Psoriasis assessment tools in clinical trials.

Metabolic disorders in patients with psoriasis and psoriatic arthritis.

Gender differences in prevalence of the metabolic syndrome in Gulf Cooperation Council Countries: a systematic review.

The metabolic syndrome: prevalence, main characteristics and association with socio-economic status in adults living in Great Tunis.

The metabolic syndrome in an Arab population: a first look at the new International Diabetes Federation criteria.

Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulin-resistant subjects.

Lipid profile, insulin secretion, and insulin sensitivity in psoriasis.

Psoriasis independently associated with hyperleptinemia contributing to metabolic syndrome.

P304

705-709

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1468-3083.2010.03856.X

http://www.w3.org/2001/XMLSchema#string

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

25

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-10-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21029207

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome